Epstein Becker Green developed an FDA regulatory and approval strategy for a digital data analytics company that usesĀ AI and machine learning to provide support and ambulatory monitoring for patients.
Epstein Becker Green developed an FDA regulatory and approval strategy for a digital data analytics company that usesĀ AI and machine learning to provide support and ambulatory monitoring for patients.